Concepedia

Author

Miho Kazui

Daiichi-Sankyo (Japan)

Also Known As

M Kazui, M. Kazui, Miho KAZUI, Miho Kazui

28

Publications

1.5K

Citations

12

H-Index

26

Concepts

All Affiliations

Daiichi-Sankyo (Japan)Eli Lilly (United States)Yokohama University of PharmacyDaiichi Sankyo (Germany)
MK

About

Miho Kazui is an author at Daiichi-Sankyo (Japan) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

188

2

Biochemistry

2

2

42

3

Health Sciences

1

1

99

4

Natural Sciences

1

1

29

5

Diabetes

1

1

99

Miho Kazui

×

17

Publications

1.5K

Citations

12

H-Index

YearCitations

Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite

Miho Kazui, Yumi Nishiya, Tomoko Ishizuka,

Drug Metabolism and Disposition

2009

808

The Biotransformation of Prasugrel, a New Thienopyridine Prodrug, by the Human Carboxylesterases 1 and 2

Eric T. Williams, Karen O. Jones, G. Douglas Ponsler,

Drug Metabolism and Disposition

2008

127

A Possible Mechanism for the Differences in Efficiency and Variability of Active Metabolite Formation from Thienopyridine Antiplatelet Agents, Prasugrel and Clopidogrel

Katsunobu Hagihara, Miho Kazui, Atsushi Kurihara,

Drug Metabolism and Disposition

2009

121

Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs.

Kenji Kawai, Y Kawasaki-Tokui, Tomoyo ODAKA,

PubMed

1997

99

Comparison of Human Cytochrome P450 Inhibition by the Thienopyridines Prasugrel, Clopidogrel, and Ticlopidine

Katsunobu Hagihara, Yumi Nishiya, Atsushi Kurihara,

Drug Metabolism and Pharmacokinetics

2008

73

Anti-HIV-1 Activities and Pharmacokinetics of New Arylpiperazinyl Fluoroquinolones

Toshinori Ohmine, Tetsushi Katsube, Yasunori Tsuzaki,

Bioorganic & Medicinal Chemistry Letters

2002

36

Comparison of formation of thiolactones and active metabolites of prasugrel and clopidogrel in rats and dogs

Katsunobu Hagihara, Miho Kazui, Hidenori Ikenaga,

Xenobiotica

2009

34

Biotransformation of Prasugrel, a Novel Thienopyridine Antiplatelet Agent, to the Pharmacologically Active Metabolite

Katsunobu Hagihara, Miho Kazui, Atsushi Kurihara,

Drug Metabolism and Disposition

2010

31

Discovery of a bicyclo[4.3.0]nonane derivative DS88790512 as a potent, selective, and orally bioavailable blocker of transient receptor potential canonical 6 (TRPC6)

Keisuke Motoyama, Tsutomu Nagata, Jun Kobayashi,

Bioorganic & Medicinal Chemistry Letters

2018

29

Hepatic Microsomal Thiol Methyltransferase Is Involved in Stereoselective Methylation of Pharmacologically Active Metabolite of Prasugrel

Miho Kazui, Katsunobu Hagihara, Takashi Izumi,

Drug Metabolism and Disposition

2014

21

Page 1